Deciphera Pharmaceuticals, Inc. Assets, Fair Value Disclosure
Deciphera Pharmaceuticals, Inc. had Assets, Fair Value Disclosure of $253.85 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2024-05-10
- 2024-03-31: Assets, Fair Value Disclosure $253.85M.
- 2023-12-31: Assets, Fair Value Disclosure $299.24M.
- 2023-09-30: Assets, Fair Value Disclosure $348.18M.
- 2023-06-30: Assets, Fair Value Disclosure $363.42M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2024-03-31 | $253.85M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $299.24M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $348.18M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $363.42M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $405.32M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $321.19M 10-K · filed 2024-02-07 |
| 2022-09-30 | $328.77M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $367.68M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $228.00M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $288.32M 10-K · filed 2023-02-07 |
| 2021-09-30 | $372.21M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $422.13M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $462.01M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $502.08M 10-K · filed 2022-02-08 |
| 2020-09-30 | $541.86M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $617.70M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $610.91M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $507.95M 10-K · filed 2021-02-09 |
| 2019-09-30 | $579.94M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $220.32M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $253.74M 10-Q · filed 2019-05-09 |